Scientific publications

Positron emission tomography in breast cancer

Richter JA, García-Velloso MJ, Domínguez I, Quincoces G, Prieto E, Rodríguez Fraile M.
Servicio de Medicina Nuclear, Clínica Universitaria, Avenida Pío XII, 36 31008 Pamplona

Magazine: Revista de Medicina de la Universidad de Navarra

Date: Feb 1, 2008

Breast Cancer Area Nuclear Medicine [SP]

PET18FDG is an imaging diagnostic technique that shows changes in glycolitic metabolism that appear at a very early phases in the tumoral process. The main limitation of PET in breast cancer is the detection of small tumor lesions and axillary micrometastases.

However it offers important information in the staging of high risk patients, in clinical relapse or in therapeutic evaluation. The new PET-CT devices offer advantages over conventional techniques. It provides a greater precision in the localization of tumoral foci. In spite of current difficulties for clinical applications, fluoro-estradiol (18F-ES) offers the possibilty of studying the presence of estrogenic receptors both in the primary and in the metastases.

It may prove to be a useful tool to obtain information about therapeutic management and prognosis of breast cancer.

CITATION  Rev Med Univ Navarra. 2008 Jan-Mar;52(1):4-12

you maybe interested


The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra


The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra


Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra